This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.93% per year. These returns cover a period from January 1, 1988 through October 6, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
The company also distributes natural gas; owns, develops and operates coal, oil, gas and renewable fuel-based electricity generating facilities; and invests in other energy-related entities. It also develops and invests in real estate.
Welltower (WELL) Q2 FFO Tops, SHO Occupancy Up, '23 View Raised
by Zacks Equity Research
Welltower's (WELL) Q2 FFO outshines estimates on better-than-anticipated revenues, driven by robust SHO portfolio performance. It raises its 2023 normalized FFO per share outlook.
Welltower (WELL) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
Although the revenue and EPS for Welltower (WELL) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Welltower (WELL) Beats Q2 FFO and Revenue Estimates
by Zacks Equity Research
Welltower (WELL) delivered FFO and revenue surprises of 4.65% and 4.79%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
What's in Store for Welltower (WELL) This Earnings Season?
by Zacks Equity Research
While Welltower's (WELL) Q2 earnings are likely to have benefited from the positive operating trends of the SHO portfolio, high interest expense might have been a deterrent.
Key Reasons to Add Crown Castle (CCI) to Your Portfolio Now
by Zacks Equity Research
The increase in demand for wireless communication assets amid rising data usage, strategic investments and a solid balance sheet present an optimistic near-term scenario for Crown Castle (CCI).
Key Reasons to Add Welltower (WELL) to Your Portfolio Now
by Zacks Equity Research
A rise in healthcare spending by senior citizens, strategic portfolio-repositioning efforts and a healthy balance sheet imply an optimistic near-term scenario for Welltower (WELL).
Welltower (WELL) Bolsters '23 View on Solid Senior Housing Trend
by Zacks Equity Research
Welltower (WELL) raises the midpoint of its 2023 normalized FFO per share guidance backed by the continued strength in the seniors housing operating portfolio and recent capital activity.
Why Is Welltower (WELL) Down 3.8% Since Last Earnings Report?
by Zacks Equity Research
Welltower (WELL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Here's Why Welltower (WELL) Shares Gain 10.5% in Past 6 Months
by Zacks Equity Research
Improving SHO portfolio fundamentals, portfolio restructuring initiatives and capital recycling efforts drive Welltower's (WELL) shares 10.5% up in the past six months.
Ventas' (VTR) Q1 FFO and Revenues Beat, SHOP NOI Increases
by Zacks Equity Research
Ventas's (VTR) Q1 earnings outshine estimates on better-than-anticipated revenues. The SHOP same-store cash NOI improves on strong pricing power and margin expansion. The company maintains its 2023 outlook.
Ventas (VTR) to Post Q1 Earnings: Is a Beat in the Cards?
by Zacks Equity Research
Ventas' (VTR) Q1 earnings are likely to have benefited from the positive operating trends of its senior housing operating portfolio and high demand for life-science real-estate assets.
Host Hotels' (HST) Q1 FFO & Revenues Beat, '23 View Raised
by Zacks Equity Research
Host Hotels' (HST) Q1 earnings outshine estimates on better-than-anticipated revenues, aided by continued strong leisure travel demand and growth in city center markets. It also raises its 2023 outlook.
Welltower (WELL) Q1 FFO Tops, SHO Occupancy Up, '23 View Raised
by Zacks Equity Research
Welltower's (WELL) Q1 earnings outshine estimates on better-than-anticipated revenues. The SHO portfolio occupancy improves year over year. The company raises its 2023 FFO per share outlook.
Welltower (WELL) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
While the top- and bottom-line numbers for Welltower (WELL) give a sense of how the business performed in the quarter ended March 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Welltower (WELL) Q1 FFO and Revenues Beat Estimates
by Zacks Equity Research
Welltower (WELL) delivered FFO and revenue surprises of 3.66% and 1.08%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Is a Beat in the Cards for Welltower (WELL) in Q1 Earnings?
by Zacks Equity Research
Welltower's (WELL) Q1 earnings are likely to have benefited from the positive operating trends in the seniors housing operating portfolio.
Vornado (VNO) to Post Q1 Earnings: Is a Beat in the Cards?
by Zacks Equity Research
Despite declining office-space demand, Vornado's (VNO) Q1 earnings are likely to have benefited from the healthy demand for its flight-to-quality office properties.
Key Factors to Impact Medical Properties' (MPW) Q1 Earnings
by Zacks Equity Research
Improving operating fundamentals of its tenants are likely to have aided Medical Properties' (MPW) Q1 earnings. However, higher interest expenses and exposure to troubled operators might have ailed.
What's in Store for SBA Communications (SBAC) in Q1 Earnings?
by Zacks Equity Research
High demand for SBA Communications' (SBAC) wireless infrastructure assets amid 5G deployment efforts by carriers is likely to have aided its Q1 earnings. However, rising interest expenses are a woe.
Is a Beat in Store for Digital Realty (DLR) in Q1 Earnings?
by Zacks Equity Research
Solid data-center demand amid enterprises' growing reliance on technology and acceleration in digital transformation strategies might have aided Digital Realty's (DLR) Q1 earnings.
Is a Beat in Store for American Tower (AMT) in Q1 Earnings?
by Zacks Equity Research
Robust demand for American Tower's (AMT) communications real estate portfolio amid global 5G deployment efforts by wireless carriers is likely to have aided its Q1 earnings.
Healthpeak (PEAK) to Post Q1 Earnings: What's in the Offing?
by Zacks Equity Research
Robust demand for Healthpeak's (PEAK) life-science assets and rising healthcare spending by senior citizens are likely to have aided its Q1 earnings. However, rising interest rates might have ailed.
What's Going On With Block Shares?
by Derek Lewis
Block shares are making headlines for all the wrong reasons today, with short-seller Hindenburg Research raising red flags surrounding the company. Whose side are you on?
Welltower (WELL) Down 9.2% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Welltower (WELL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Is it Wise to Hold on to Healthpeak (PEAK) Stock for Now?
by Zacks Equity Research
Healthpeak's (PEAK) focus on enhancing its life-science real-estate assets, capital-recycling moves and a solid balance sheet bodes well. Stiff competition from peers and rising interest rates are woes.